Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Artificial T-cell receptors.

M Pule1, H Finney, A Lawson

  • 1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.

Cytotherapy
|July 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands.

British journal of clinical pharmacology·2025
Same author

Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Assessment of TB underreporting by level of reporting system in Lagos, Nigeria.

Public health action·2022
Same author

Scaling Up Maternal Mental healthcare by Increasing access to Treatment (SUMMIT) through non-specialist providers and telemedicine: a study protocol for a non-inferiority randomized controlled trial.

Trials·2021
Same author

Generation of a neutralizing antibody against RD114-pseudotyped viral vectors.

The Journal of general virology·2019
Same author

Integration of animal health and public health surveillance sources to exhaustively inform the risk of zoonosis: An application to visceral leishmaniasis data in Brazil.

Spatial and spatio-temporal epidemiology·2019
Same journal

CAR T cells: The next frontier.

Cytotherapy·2026
Same journal

Dialysis bioreactor enables high-density, serum-free expansion of dental pulp-derived mesenchymal stromal cells with enhanced secretome.

Cytotherapy·2026
Same journal

Beyond the synapses: should we anticipate neurotransmitter signaling when manufacturing CAR-T cells for brain tumors?

Cytotherapy·2026
Same journal

Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapy.

Cytotherapy·2026
Same journal

Manufacturing strategies for prolonged CAR-T cell persistence.

Cytotherapy·2026
Same journal

Overcoming five main challenges to targeting hematologic malignancies.

Cytotherapy·2026
See all related articles

Artificial T-cell receptors (TCRs) offer a novel approach to immunotherapy by enabling the engineering of T cells with specific antigen recognition. This technology shows promise for treating conditions like cancer and HIV infection.

Area of Science:

  • Immunology
  • Biotechnology
  • Molecular Biology

Background:

  • Artificial T-cell receptors (TCRs) are engineered molecules combining antigen-binding domains with signaling endodomains.
  • Commonly, ectodomains are derived from antibody or TCR variable chains, while endodomains often utilize CD-zeta.
  • CD-zeta signaling, while inducing IFN-γ release and cell killing, has limitations in transmitting full T-cell activation signals.

Purpose of the Study:

  • To explore the design and application of artificial T-cell receptors for enhanced T-cell-based immunotherapies.
  • To investigate methods for improving T-cell activation signals beyond traditional CD-zeta signaling.
  • To highlight the potential of artificial TCRs in generating specific T cells efficiently for therapeutic purposes.

Main Methods:

Related Experiment Videos

  • Constructing artificial T-cell receptors by linking antigen-recognizing ectodomains to signaling endodomains.
  • Utilizing various ectodomain designs and exploring novel endodomain combinations for enhanced signaling.
  • Employing gene transfer techniques to introduce artificial TCRs into T cells.

Main Results:

  • Combinations of signaling molecule segments in endodomains facilitate more potent T-cell activation, including proliferation.
  • Artificial TCRs enable the grafting of virtually any specificity onto T cells, bypassing laborious selection processes.
  • Demonstrated efficacy against tumors in animal models and successful Phase I/II studies in HIV-infected individuals.

Conclusions:

  • Artificial T-cell receptors represent a rapidly advancing technology with significant potential for adoptive immunotherapy.
  • This approach allows for the generation of large numbers of antigen-specific T cells efficiently.
  • Further development of artificial TCRs promises new therapeutic strategies for various diseases, including cancer and infectious diseases.